IGC Pharma Inc (IGC) – key numbers that make it a Strong Buy For Now

IGC Pharma Inc (AMEX: IGC) is -11.00% lower on its value in year-to-date trading and has touched a low of $0.25 and a high of $0.50 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The IGC stock was last observed hovering at around $0.38 in the last trading session, with the day’s loss setting it -0.01%.

Currently trading at $0.37, the stock is 16.54% and 19.35% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 3.06 million and changing -1.60% at the moment leaves the stock 12.84% off its SMA200. IGC registered 11.52% gain for a year compared to 6-month loss of 13.08%. The firm has a 50-day simple moving average (SMA 50) of $0.3144 and a 200-day simple moving average (SMA200) of $0.33245.

The stock witnessed a 21.07% gain in the last 1 month and extending the period to 3 months gives it a 39.29%, and is 18.09% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 15.24% over the week and 6.43% over the month.

IGC Pharma Inc (IGC) has around 70 employees, a market worth around $31.44M and $1.27M in sales. Profit margin for the company is -560.27%. Distance from 52-week low is 48.40% and -24.76% from its 52-week high. The company has generated returns on investments over the last 12 months (-109.99%).

.

IGC Pharma Inc (IGC) Top Institutional Holders

26.0 institutions hold shares in IGC Pharma Inc (IGC), with institutional investors hold 21.89% of the company’s shares. The shares outstanding are 80.88M, and float is at 57.25M with Short Float at 0.89%. Institutions hold 19.89% of the Float.

The top institutional shareholder in the company is BLACKROCK INC. with over 0.7 million shares valued at $0.31 million. The investor’s holdings represent 1.1961% of the IGC Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 0.65 million shares valued at $0.28 million to account for 1.0965 of the shares outstanding. The other top investors are GEODE CAPITAL MANAGEMENT, LLC which holds 0.43 million shares representing 0.7305% and valued at over $0.19 million, while STATE STREET CORP holds 0.2809 of the shares totaling 0.17 million with a market value of $71710.0.

IGC Pharma Inc (IGC) Insider Activity

The most recent transaction is an insider purchase by Moran James P, the company’s Director. SEC filings show that Moran James P bought 588,235 shares of the company’s common stock on Sep 25 ’24 at a price of $0.34 per share for a total of $0.2 million. Following the purchase, the insider now owns 0.94 million shares.

Related Posts

News RTS
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.